Staphylococcus aureus Prosthetic Valve Endocarditis: Optimal Management and Risk Factors for Death
The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
The mortality rate associated with Staphylococcus aureus prosthetic valve endocarditis (PVE) remains high. To identify clinical events associated with an increased risk of death among patients with S. aureus PVE and to evaluate the role of valve replacement surgery in reducing mortality, we conducted a retrospective cohort study of patients who met strict criteria for definite S. aureus PVE. The primary endpoint for the study was survival at 3 months from the date of diagnosis. S. aureus PVE was diagnosed in 33 patients. Of these, 14 (42%) died within 90 days of the diagnosis. Cardiac complications were detected in 22 (67%), and central nervous system (CNS) complications were detected in 11 (33%). A stepwise logistic regression multivariate model demonstrated that cardiac complications, but not CNS complications, were associated with increased mortality and that performing valve replacement surgery during antibiotic therapy was associated with decreased mortality. These associations were confirmed by using a Cox proportional hazards model with time-dependent covariates to control for survival bias. Performing valve replacement surgery during antimicrobial therapy will reduce the mortality among patients with S. aureus PVE, even those without evidence of cardiac complications.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Early cardiac surgical interventions play an important role in maximizing outcomes in S aureus PVE, 186 especially in the presence of heart failure.”
Citations
Cites
(1990) · Choice Reviews Online · doi:10.5860/choice.27-3338 · Cited by 35,305
Regression Models and Life-Tables
Cox, D. R. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_37 · Cited by 26,297
Durack, D. T., Lukes, A. S., Bright, D. K., & Service, D. E. (1994) · The American Journal of Medicine · doi:10.1016/0002-9343(94)90143-0 · Cited by 2,572
Prosthetic valve endocarditis.
Ivert, T. S., Dismukes, W. E., Cobbs, C. G., Blackstone, E. H., Kirklin, J. W., & Bergdahl, L. A. (1984) · Circulation · doi:10.1161/01.cir.69.2.223 · Cited by 498 · cited 1×
“7% within 60 months after surgery [1-4].”
NEUROLOGIC COMPLICATIONS OF BACTERIAL ENDOCARDITIS
PRUITT, A. A., RUBIN, R. H., KARCHMER, A. W., & DUNCAN, G. W. (1978) · Medicine · doi:10.1097/00005792-197807000-00004 · Cited by 419
Self-citationSurgical management of infective endocarditis associated with cerebral complications
Eishi, K., Kawazoe, K., Kuriyama, Y., Kitoh, Y., Kawashima, Y., & Omae, T. (1995) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(95)70038-2 · Cited by 299
Risk factors for the development of prosthetic valve endocarditis.
Calderwood, S. B., Swinski, L. A., Waternaux, C. M., Karchmer, A. W., & Buckley, M. J. (1985) · Circulation · doi:10.1161/01.cir.72.1.31 · Cited by 271 · cited 2×
“Early PVE was defined as that occurring < 12 months after valve implantation, whereas late PVE was defined as that beginning > 12 months after valve implantation, as previously defined [2].”
MethodSelf-citationStroke in infective endocarditis.
Hart, R. G., Foster, J. W., Luther, M. F., & Kanter, M. C. (1990) · Stroke · doi:10.1161/01.str.21.5.695 · Cited by 254 · cited 1×
“aureus PVE [22-24].”
Masur, H., & Johnson, W. D. (1980) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(19)37824-9 · Cited by 202
Valve replacement in patients with endocarditis and acute neurologic deficit
Gillinov, A. M., Shah, R. V., Curtis, W. E., Scott Stuart, R., Cameron, D. E., Baumgartner, W. A., & Greene, P. S. (1996) · The Annals of Thoracic Surgery · doi:10.1016/0003-4975(96)00014-8 · Cited by 186 · cited 2×
“Recent studies have suggested that worsening of the CNS deficit may be diminished by delaying surgery for 10-14 days after cerebral infarction and for perhaps as long as 4 weeks after cerebral hemorrhage [19, 20, 25].”
Background
Cited by
Tong, S. Y. C., Davis, J. S., Eichenberger, E., Holland, T. L., & Fowler, V. G. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00134-14 · Cited by 5,192
Habib, G., Lancellotti, P., Antunes, M. J., Bongiorni, M. G., Casalta, J.-P., Del Zotti, F., Dulgheru, R., El Khoury, G., Erba, P. A., Iung, B., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv319 · Cited by 4,997
Liu, C., Bayer, A., Cosgrove, S. E., Daum, R. S., Fridkin, S. K., Gorwitz, R. J., Kaplan, S. L., Karchmer, A. W., Levine, D. P., Murray, B. E., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/ciq146 · Cited by 4,191
Self-citationBaddour, L. M., Wilson, W. R., Bayer, A. S., Fowler, V. G., Tleyjeh, I. M., Rybak, M. J., Barsic, B., Lockhart, P. B., Gewitz, M. H., Levison, M. E., et al. (2015) · Circulation · doi:10.1161/cir.0000000000000296 · Cited by 3,232
Treatment of Infections Associated with Surgical Implants
Darouiche, R. O. (2004) · New England Journal of Medicine · doi:10.1056/nejmra035415 · Cited by 2,257
Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009)
Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and by the International Society of Chemotherapy (ISC) for Infection and Cancer, Habib, G., Hoen, B., Tornos, P., Thuny, F., Prendergast, B., Vilacosta, I., Moreillon, P., de Jesus Antunes, M., Thilen, U., et al. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp285 · Cited by 2,014
Baddour, L. M., Wilson, W. R., Bayer, A. S., Fowler, V. G., Bolger, A. F., Levison, M. E., Ferrieri, P., Gerber, M. A., Tani, L. Y., Gewitz, M. H., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.165564 · Cited by 1,707
Infective Endocarditis in Adults
Mylonakis, E., & Calderwood, S. B. (2001) · New England Journal of Medicine · doi:10.1056/nejmra010082 · Cited by 1,324
Self-citationBaltimore, R. S., Gewitz, M., Baddour, L. M., Beerman, L. B., Jackson, M. A., Lockhart, P. B., Pahl, E., Schutze, G. E., Shulman, S. T., & Willoughby, R. (2015) · Circulation · doi:10.1161/cir.0000000000000298 · Cited by 398
“The overall mortality rate associated with prosthetic valve endocarditis is relatively high but is highest for infections caused by S aureus.(128) Although 1 study reporting cases from the 1970s showed that many cases of pediatric IE with patches or prostheses could be treated successfully with medical management alon…”
BackgroundChamis, A. L., Peterson, G. E., Cabell, C. H., Corey, G. R., Sorrentino, R. A., Greenfield, R. A., Ryan, T., Reller, L. B., & Fowler, V. G. (2001) · Circulation · doi:10.1161/hc3401.095097 · Cited by 292
Lalani, T. (2013) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.8203 · Cited by 284
“Viridans group streptococci 56 (11) 68 (13) .”
Unique Features of Infective Endocarditis in Childhood
Ferrieri, P., Gewitz, M. H., Gerber, M. A., Newburger, J. W., Dajani, A. S., Shulman, S. T., Wilson, W., Bolger, A. F., Bayer, A., Levison, M. E., et al. (2002) · Circulation · doi:10.1161/01.cir.0000013073.22415.90 · Cited by 278
Serious Infections Caused by Methicillin‐Resistant Staphylococcus aureus
Boucher, H., Miller, L. G., & Razonable, R. R. (2010) · Clinical Infectious Diseases · doi:10.1086/653519 · Cited by 252
Anguera, I., Miro, J. M., Vilacosta, I., Almirante, B., Anguita, M., Muñoz, P., Roman, J. A. S., de Alarcon, A., Ripoll, T., Navas, E., et al. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi034 · Cited by 250
Rifampin Combination Therapy for Nonmycobacterial Infections
Forrest, G. N., & Tamura, K. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00034-09 · Cited by 242
“aureus because of the high rate of mortality caused by this infection (133).”
BackgroundInfective Endocarditis Due to Staphylococcus aureus: Deleterious Effect of Anticoagulant Therapy
Tornos, P., Almirante, B., Mirabet, S., Permanyer, G., Pahissa, A., & Soler-Soler, J. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.5.473 · Cited by 214
Prosthetic Valve Endocarditis: Current Approach and Therapeutic Options
Habib, G., Thuny, F., & Avierinos, J.-F. (2008) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2007.10.007 · Cited by 194
Prosthetic valve endocarditis: who needs surgery? A multicentre study of 104 cases
Habib, G., Tribouilloy, C., Thuny, F., Giorgi, R., Brahim, A., Amazouz, M., Remadi, J.-P., Nadji, G., Casalta, J.-P., Coviaux, F., et al. (2005) · Heart · doi:10.1136/hrt.2004.046177 · Cited by 181
BOUZA, E., MENASALVAS, A., MUÑOZ, P., VASALLO, F. J., MORENO, M. D. M., & FERNÁNDEZ, M. A. G. (2001) · Medicine · doi:10.1097/00005792-200109000-00003 · Cited by 177
Wang, A., Pappas, P., Anstrom, K. J., Abrutyn, E., Fowler, V. G., Hoen, B., Miro, J. M., Corey, G. R., Olaison, L., Stafford, J. A., et al. (2005) · American Heart Journal · doi:10.1016/j.ahj.2005.01.023 · Cited by 159
“In contrast, an earlier, retrospective study reported a survival benefit of early surgery in S aureus PVIE regardless of the presence of cardiac complications.(29) These disparate conclusions were likely because of significant differences in study designs, populations, and particularly, timing of the survival end poin…”
ResultChirouze, C., Cabell, C. H., Fowler, V. G., Khayat, N., Olaison, L., Miro, J. M., Habib, G., Abrutyn, E., Eykyn, S., Corey, G. R., et al. (2004) · Clinical Infectious Diseases · doi:10.1086/383035 · Cited by 153
Unique Features of Infective Endocarditis in Childhood
Ferrieri, P., Gewitz, M. H., Gerber, M. A., Newburger, J. W., Dajani, A. S., Shulman, S. T., Wilson, W., Bolger, A. F., Bayer, A. S., Levison, M. E., et al. (2002) · PEDIATRICS · doi:10.1542/peds.109.5.931 · Cited by 158
Mourvillier, B., Trouillet, J., Timsit, J., Baudot, J., Chastre, J. E., Regnier, B., Gibert, C., & Wolff, M. (2004) · Intensive Care Medicine · doi:10.1007/s00134-004-2436-9 · Cited by 162
“aureus PVE valve replacement combined with medical therapy is associated with a better outcome than medical treatment alone [6, 8, 26, 29].”
BackgroundStaphylococcus aureus bacteremia and endocarditis
Petti, C. A., & Fowler, V. G. (2003) · Cardiology Clinics · doi:10.1016/s0733-8651(03)00030-4 · Cited by 155
Endocarditis and Intravascular Infections
Fowler, V. G., Scheld, W. M., & Bayer, A. S. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-4801-3.00082-5 · Cited by 152
Predictors of Death and Impact of Surgery in Staphylococcus aureus Infective Endocarditis
Rémadi, J. P., Habib, G., Nadji, G., Brahim, A., Thuny, F., Casalta, J., Peltier, M., & Tribouilloy, C. (2007) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2006.09.093 · Cited by 136
Periannular Complications in Infective Endocarditis Involving Prosthetic Aortic Valves
Anguera, I., Miró, J. M., Román, J. A. S., de Alarcón, A., Anguita, M. P., Almirante, B., Evangelista, A., Cabell, C. H., Vilacosta, I., Ripoll, T., et al. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2006.05.066 · Cited by 133
Fernández Guerrero, M. L., González López, J. J., Goyenechea, A., Fraile, J., & de Górgolas, M. (2009) · Medicine · doi:10.1097/md.0b013e318194da65 · Cited by 121
“Valve replacement was more frequently needed and more rapidly performed in patients with PVE than in their counterparts with NVE.”
BackgroundResultInfluentialManagement of Methicillin‐ResistantStaphylococcus aureusBacteremia
Cosgrove, S. E., & Fowler, V. G. (2008) · Clinical Infectious Diseases · doi:10.1086/533595 · Cited by 133
“aureus endocarditis are likely to benefit from early surgical intervention [18-21].”
BackgroundRisk of endocarditis among patients with prosthetic valves and Staphylococcus aureus bacteremia
El-Ahdab, F., Benjamin, D. K., Wang, A., Cabell, C. H., Chu, V. H. Y., Stryjewski, M. E., Corey, G. R., Sexton, D. J., Reller, L. B., & Fowler, V. G. (2005) · The American Journal of Medicine · doi:10.1016/j.amjmed.2004.12.017 · Cited by 125
Revest, M., Camou, F., Senneville, E., Caillon, J., Laurent, F. J., Calvet, B., Feugier, P., Batt, M., & Chidiac, C. (2015) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2015.04.014 · Cited by 124
“Given that PVGIs are severe infections on foreign materials, addition of an aminoglycoside, preferably gentamicin, is justified [59,93–95].”
BackgroundEarly onset prosthetic valve endocarditis: the Cleveland Clinic Experience 1992–1997
Gordon, S. M., Serkey, J. M., Longworth, D. L., Lytle, B. W., & Cosgrove, D. M. (2000) · The Annals of Thoracic Surgery · doi:10.1016/s0003-4975(00)01135-8 · Cited by 122
Long‐Term Outcome of Infective Endocarditis: The Impact of Early Surgical Intervention
Bishara, J., Leibovici, L., Gartman‐Israel, D., Sagie, A., Kazakov, A., Miroshnik, E., Ashkenazi, S., & Pitlik, S. (2001) · Clinical Infectious Diseases · doi:10.1086/323785 · Cited by 109
“aureus endocarditis [20].”
Indications and optimal timing for surgery in infective endocarditis
Delahaye, F., Célard, M., Roth, O., & de Gevigney, G. (2004) · Heart · doi:10.1136/hrt.2003.029967 · Cited by 116
Chirouze, C., Alla, F., Fowler, V. G., Sexton, D. J., Corey, G. R., Chu, V. H., Wang, A., Erpelding, M.-L., Durante-Mangoni, E., Fernández-Hidalgo, N., et al. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/ciu871 · Cited by 104
Lefort, A., Mainardi, J.-L., Selton-Suty, C., Casassus, P., Guillevin, L., & Lortholary, O. (2000) · Medicine · doi:10.1097/00005792-200009000-00006 · Cited by 102
Truninger, K., Jost, C. H. A., Seifert, B., Vogt, P. R., Follath, F., Schaffner, A., & Jenni, R. (1999) · Heart · doi:10.1136/hrt.82.6.714 · Cited by 100
“endocarditis even in the absence of cardiac complications may well be true.”
BackgroundGalar, A., Weil, A. A., Dudzinski, D. M., Muñóz, P., & Siedner, M. J. (2019) · Clinical Microbiology Reviews · doi:10.1128/cmr.00041-18 · Cited by 103
“Health care-associated disease, staphylococcal or fungal etiologies, older age, diabetes mellitus, early PVE, heart failure, CNS embolic disease, and intracardiac abscess are predictive of worse clinical outcomes (1, 3, 8, 13, 65, 205).”
BackgroundMouly, S. J., Ruimy, R., Launay, O., Arnoult, F., Brochet, É., Trouillet, J. L., Leport, C., & Wolff, M. (2002) · Journal of Infection · doi:10.1053/jinf.2002.1058 · Cited by 99
Infections of intracardiac devices
Karchmer, A. W., & Longworth, D. L. (2002) · Infectious Disease Clinics of North America · doi:10.1016/s0891-5520(01)00005-8 · Cited by 91
“004) by surgical intervention during antimicrobial therapy [51].”
BackgroundMethodSelf-citationRisk of Endocarditis Among Patients With Prosthetic Valves and Staphylococcus aureus Bacteremia
El-Ahdab, F., Benjamin, K., & Wang, A. (2005) · ACC Current Journal Review · doi:10.1016/j.accreview.2005.06.067 · Cited by 81
Nataloni, M., Pergolini, M., Rescigno, G. U., & Mocchegiani, R. (2010) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0b013e328336ec9a · Cited by 89
Staphylococcus aureus bacteremia and endocarditis
Petti, C. A., & Fowler, V. G. (2002) · Infectious Disease Clinics of North America · doi:10.1016/s0891-5520(01)00003-4 · Cited by 85
“Surgery is usually required, and performing valve replacement surgery early in the course of antimicrobial therapy may be associated with improved outcome [119].”
BackgroundInfluentialRole of aminoglycosides in the treatment of bacterial endocarditis
Graham, J., & Gould, F. K. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/49.3.437 · Cited by 81
“aureus, valve replacement surgery during medical therapy, even in the absence of cardiac complications, improves outcome.(59) Duration of therapy will depend on surgical findings and peri-operative culture results, essentially 6 weeks of therapy is given following valve replacement if cultures are positive or there is…”
BackgroundRivas, P., Alonso, J. M., Moya, J., Górgolas, M., Martinell, J., & Guerrero, M. L. F. (2005) · CHEST Journal · doi:10.1378/chest.128.2.764 · Cited by 81
Medical Versus Surgical Management of Staphylococcus aureus Prosthetic Valve Endocarditis
Sohail, M. R., Martin, R. K., Wilson, W. R., Baddour, L. M., Harmsen, W. S., & Steckelberg, J. M. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.09.037 · Cited by 79
Staphylococcus aureus Bacteremia, Risk Factors, Complications, and Management
Keynan, Y., & Rubinstein, E. (2013) · Critical Care Clinics · doi:10.1016/j.ccc.2013.03.008 · Cited by 80
Loupa, C. V., Mavroidi, N., Boutsikakis, I., Paniara, O., Deligarou, O., Manoli, H., & Saroglou, G. (2004) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2004.00884.x · Cited by 82
“These numbers are much higher than the figures reported previously [8,24].”
BackgroundResultInfluentialLefort, A. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.21.2450 · Cited by 72
“Men/women 33/23 (59/41) 18/11 (62/38) Age, median (range), y 59 (18-91) 66 (37-97) Underlying medical disease† 26 (46) 8 (28) Diabetes mellitus 6 (11)† 4 (14) Chronic alcoholism 15 (27) 4 (14) Malignancy 11 (20)‡ 2 (7) Cirrhosis 5 (9)‡ 1 (4)§ Underlying heart disease† 26 (48) 20 (71)§ Prosthetic valve 10 (18) 3 (11)§…”
BackgroundInfluentialSwedish guidelines for diagnosis and treatment of infective endocarditis
Westling, K., Aufwerber, E., Ekdahl, C., Friman, G., Gårdlund, B., Julander, I., Olaison, L., Olesund, C., Rundström, H., Snygg‐Martin, U., et al. (2007) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365540701534517 · Cited by 66
Infections Associated with Long-Term Prosthetic Devices
Sampedro, M. F., & Patel, R. (2007) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2007.07.001 · Cited by 65
Infections of intracardiac devices
Karchmer, A. W., & Longworth, D. L. (2003) · Cardiology Clinics · doi:10.1016/s0733-8651(03)00032-8 · Cited by 66
Self-citationWeems, J. J. (2001) · Postgraduate Medicine · doi:10.3810/pgm.2001.10.1042 · Cited by 62
“Recent data suggest that prosthesis replacement combined with intravenous antibiotic therapy is the preferred approach in all cases of S aureus prosthetic valve endocarditis.(9)”
BackgroundGudiol, F., Aguado, J. M., Pascual, Á., Pujol, M., Almirante, B., Miró, J. M., Cercenado, E., Domínguez, M. D. L. Á., Soriano, À., Rodríguez‐Baño, J., et al. (2009) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/j.eimc.2008.09.003 · Cited by 63
Infective Endocarditis: a Diagnostic and Therapeutic Challenge for the New Millennium
Hogevik, H. (2000) · Scandinavian Journal of Infectious Diseases · doi:10.1080/003655400750044908 · Cited by 60
“In a recent retrospective multivariate analysis, the presence of cardiac complications and surgical replacements of valves during treatment were the only independent predictors of outcome (66).”
Índice de risco de mortalidade por endocardite infecciosa: um modelo logístico multivariado
da Costa, M. A. C., Wollmann, D. R., Campos, A. C. L., da Cunha, C. L. P., de Carvalho, R. G., de Andrade, D. F., & Loures, D. R. D. R. (2007) · Brazilian Journal of Cardiovascular Surgery · doi:10.1590/s0102-76382007000200007 · Cited by 59
“however, the presence of neurological complications does not increase mortality [25].”
BackgroundBacteremia, Sepsis, and Infective Endocarditis Associated with Staphylococcus aureus
Bergin, S. P., Holland, T. L., Fowler, V. G., & Tong, S. Y. C. (2015) · Current topics in microbiology and immunology · doi:10.1007/82_2015_5001 · Cited by 50
Pawar, P. D., Shin, P. K., Mousa, S. A., Ross, J., & Κωνσταντόπουλος, Κ. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.2.1258 · Cited by 46
“Staphylococcus aureus is a major pathogen involved in endovascular infections such as infective endocarditis (IE)(3) (1, 2), suppurative thrombophlebitis (3), and vascular or heart valve prosthetic infection (4).”
BackgroundInfective endocarditis: diagnosis and management
Haldar, S. M., & O’Gara, P. T. (2006) · Nature Clinical Practice Cardiovascular Medicine · doi:10.1038/ncpcardio0535 · Cited by 42
“aureus prosthetic valve endocarditis is rarely eradicated with antibiotics alone, and retrospective analyses suggest that combined medical and surgical therapy is more effective than medical therapy alone”
BackgroundDo all patients with prosthetic valve endocarditis need surgery?
Attaran, S., Chukwuemeka, A., Punjabi, P. P., & Anderson, J. (2012) · Interactive CardioVascular and Thoracic Surgery · doi:10.1093/icvts/ivs372 · Cited by 37
“[8], 1997, Clin Infect Dis”
López, J., Sevilla, T., Vilacosta, I., García, H. G., Sarriá, C., Pozo, E., Silva, J., Revilla, A., Varvaro, G., Tamarit, M. D. P., et al. (2013) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2012.10.022 · Cited by 45
Surgical Versus Medical Therapy for Prosthetic Valve Endocarditis: A Meta-Analysis of 32 Studies
Mihos, C. G., Capoulade, R., Yucel, E., Picard, M. H., & Santana, O. (2017) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2016.09.083 · Cited by 35
Prosthetic valve endocarditis: state of the heart
Nagpal, A., Sohail, M. R., & Steckelberg, J. M. (2012) · Clinical Investigation · doi:10.4155/cli.12.70 · Cited by 31
Guías de práctica clínica de la Sociedad Española de Cardiología en endocarditis
Vallés, F., Anguita, M. P., Escribano, M. P., Casar, F. P., Sanfeliú, H. P., Tornos, P., & Vilacosta, M. (2000) · Revista Española de Cardiología · doi:10.1016/s0300-8932(00)75245-6 · Cited by 40
Staphylococcus aureus, platelets, and the heart
Yeaman, M. R., & Bayer, A. S. (2000) · Current Infectious Disease Reports · doi:10.1007/s11908-000-0005-0 · Cited by 30
Prosthetic Valve Endocarditis in a Multicenter Registry of Chinese Patients
Hee-Hwa, H., Chung-Wah, S., Kai-Hang, Y., Hung-Fat, T., Wing-Hung, C., & Wing-Hing, C. (2010) · Asian Cardiovascular and Thoracic Annals · doi:10.1177/0218492310379457 · Cited by 28
“This observation is also consistent with previous studies.(19,20) When a patient with PVE develops severe heart failure, this should prompt a more aggressive approach with a strong consideration of valve surgery.”
ResultEndocarditis and Intravascular Infections
Fowler, V. G., Scheld, W. M., & Bayer, A. S. (2010) · Elsevier eBooks · doi:10.1016/b978-0-443-06839-3.00077-1 · Cited by 38
Infections of Prosthetic Heart Valves
Karchmer, A. W. (2014) · ASM Press eBooks · doi:10.1128/9781555818067.ch8 · Cited by 29
Self-citationQuantitative Histological Examination of Mechanical Heart Valves
Lépidi, H., Casalta, J., Fournier, P., Habib, G., Collart, F., & Raoult, D. (2005) · Clinical Infectious Diseases · doi:10.1086/427504 · Cited by 28
“aureus [1, 18-20].”
Habib, G., Hoen, B., Tornos, P., Thuny, F., Prendergast, B., Vilacosta, I., Moreillon, P., Antunes, M. J., Thilén, U. J., Lekakis, J. P., et al. (2009) · Revista Española de Cardiología · doi:10.1016/s0300-8932(09)73131-8 · Cited by 43
Almirante, B., & Miró, J. M. (2008) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/s0213-005x(08)75281-9 · Cited by 28
Management of Antimicrobials in Infectious Diseases
Mainous, A. G., III, & Pomeroy, C. (2000) · Humana Press eBooks · doi:10.1007/978-1-59259-036-0 · Cited by 20
Abdallah, L., Habib, G., Rémadi, J. P., Salaün, E., Casalta, J., & Tribouilloy, C. M. (2016) · Archives of cardiovascular diseases · doi:10.1016/j.acvd.2016.02.010 · Cited by 25
Daum, R. S. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-40181-4.00115-8 · Cited by 16
Infective endocarditis 2006: indications for surgery.
O’Gara, P. T. (2007) · PubMed · Cited by 16
Thomsen, I. P., & Creech, C. B. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-75608-2.00115-4 · Cited by 15
Lowell, G. S., & Daum, R. S. (2008) · Elsevier eBooks · doi:10.1016/b978-0-7020-3468-8.50121-8 · Cited by 15
The serological diagnosis of staphylococcal infective endocarditis
Watkin, R. W., Lang, S., Lambert, P. A., Littler, W. A., & Elliott, T. (2006) · Journal of Infection · doi:10.1016/j.jinf.2005.12.009 · Cited by 14
“Prosthetic valve involvement has a worse prognosis with a 42% 90 day mortality, 67% having cardiac complications and 33% developing central nervous system complications.(8) S.”
BackgroundLópez, J., Sevilla, T., Vilacosta, I., García, H. G., Sarriá, C., Pozo, E., Silva, J., Revilla, A., Varvaro, G., del Palacio, M., et al. (2013) · Revista Española de Cardiología · doi:10.1016/j.recesp.2012.10.026 · Cited by 15
“Staphylococcus aureus 13 (21) 6 (7) 0,013 Polimicrobiana 4 (7) 17 (20) 0,021”
Pronóstico hospitalario de la endocarditis protésica tras cirugía urgente
Revilla, A., López, J., Sevilla, T., Villacorta, E., Sarriá, C., Manzano, M. D. C., Fulquet, E., Pozo, E., Mota, P., Gómez, I., et al. (2009) · Revista Española de Cardiología · doi:10.1016/s0300-8932(09)73124-0 · Cited by 13
Astigarraga, P. M. O., Garnacho‐Montero, J., Grau, S., Colomo, Ó. R., Palomar, M., Zaragoza, R., García-Paredes, P. M., Cerdá, E., & Lerma, F. Á. (2007) · Medicina Intensiva · doi:10.1016/s0210-5691(07)74829-5 · Cited by 12
In-Hospital Prognosis of Prosthetic Valve Endocarditis After Urgent Surgery
Revilla, A., López, J., Sevilla, T., Villacorta, E., Sarriá, C., Manzano, M. D. C., Fulquet, E., Pozo, E., Mota, P., Gómez, I., et al. (2009) · Revista Española de Cardiología (English Edition) · doi:10.1016/s1885-5857(09)73533-9 · Cited by 12
“8 Nevertheless, surgery for PVE is complex and involves high mortality, between 15% and 64% according to different series.(5,8-10) Furthermore, it has been demonstrated that urgent surgery for infective endocarditis (IE) is an important predictor of in-hospital mortality due to complications and severe clinical deteri…”
BackgroundAddressing Medical Device Challenges with Drug–Device Combinations
Avula, M., & Grainger, D. W. (2015) · Wiley eBooks · doi:10.1002/9781119002956.ch01 · Cited by 12
Siaperas, P., Pefanis, A. V., Iliopoulos, D., Katsarolis, I., Kyroudi-Voulgari, A., Donta, I., Karayiannakos, P., & Giamarellou, H. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.12.3531-3537.2001 · Cited by 11
“Early combined medical and surgical intervention is more beneficial than medical therapy alone in both native-and prosthetic-valve IE; thus, a more aggressive surgical approach has been recommended during the last 10 years (12, 21, 32).”
BackgroundClinical features and prognosis of prosthetic valve endocarditis due to Staphylococcus aureus
Diego‐Yagüe, I., Ramos, A., Muñóz, P., Martínez‐Sellés, M., Machado, M., de Alarcón, A., Miró, J. M., Rodríguez-Gacía, R., Gutiérrez-Díez, J. F., Hidalgo-Tenorio, C., et al. (2024) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-024-04848-1 · Cited by 10
Valle, H. A., Fariñas-Álvarez, C., Marco, J. M. B., García-Palomo, J. D., Gutiérrez-Díez, F., Martín‐Durán, R., de Berrazueta, J. R., González-Macías, J., Revuelta-Soba, J. M., & Fariñas, M. C. (2010) · Revista Española de Cardiología · doi:10.1016/s0300-8932(10)70006-3 · Cited by 10
“Estafilococo coagulasa negativo 18 (29,5) 18 (37,5) 1,3 (0,7-2,1) 0,40”
Infections associated with implanted medical devices
Millar, M. R., & Wareham, D. W. (2010) · Elsevier eBooks · doi:10.1016/b978-0-7020-4064-1.00042-7 · Cited by 11
Clinical Syndromes of Device-Associated Infections
Sammons, J. S., & Gerber, J. S. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-40181-4.00100-6 · Cited by 10
Infective endocarditis: a review of the best treatment options
Calza, L., Manfredi, R., & Chiodo, F. (2004) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.5.9.1899 · Cited by 12
“The combination of nafcillin and gentamicin has been evaluated extensively in vitro and in vivo, and a close correlation has been observed between in vitro synergy and enhanced in vivo outcomes in experimental IE documented by most authors [5,53].”
BackgroundMiyata, E., Satoh, S., Inokuchi, K., Aso, A., Kimura, Y., Yokoyama, S., Mori, E., Nakamura, T., Matsumoto, T., Fujino, Y., et al. (2007) · Circulation Journal · doi:10.1253/circj.71.1488 · Cited by 8
Pathogenesis of Staphylococcus aureus in Humans
Lu, T., & DeLeo, F. R. (2015) · Wiley eBooks · doi:10.1002/9781118644843.ch39 · Cited by 11
Daniel, W. G., & Flachskampf, F. A. (2009) · doi:10.1093/med/9780199566990.003.022 · Cited by 8
Prosthetic Valve Endocarditis: Diagnostic Approach and Treatment Options
Starakis, I., & Mazokopakis, E. E. (2009) · Cardiovascular & Haematological Disorders - Drug Targets · doi:10.2174/1871529x10909040249 · Cited by 7
Elbey, M. A., Kalkan, M. E., Akdağ, S., Özbek, K., Eren, N. K., Demirtaş, S., Akıl, M. A., Topçu, S., Oylumlu, M., Bilik, Z., et al. (2013) · Cardiology Journal · doi:10.5603/cj.2013.0079 · Cited by 10
“Surgical treatment for PVE is complex and involves high mortality, between 15% and 64% according to different series [15, 19].”
BackgroundAstigarraga, P. M. O., Garnacho‐Montero, J., Grau, S., Colomo, Ó. R., Palomar, M., Zaragoza, R., García-Paredes, P. M., Cerdá, E., & Lerma, F. Á. (2007) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1157/13108709 · Cited by 9
JCS 2026 Guideline on the Management of Infective Endocarditis
Izumi, C., Daimon, M., Kaji, S., Masumoto, A., Ashihara, K., Amano, M., Uemura, S., Ota, H., Ohara, T., Okada, K., et al. (2026) · Circulation Journal · doi:10.1253/circj.cj-25-0987 · Cited by 7
Daum, R. S. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-2702-9.00117-3 · Cited by 6
Karchmer, A. W., & Bayer, A. S. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/ciu877 · Cited by 5
Self-citationAstigarraga, P. M. O., Garnacho‐Montero, J., Grau, S., Colomo, Ó. R., Palomar, M., Zaragoza, R., García-Paredes, P. M., Cerdá, E., & Álvarez-Lerma, F. (2007) · Farmacia Hospitalaria · doi:10.1016/s1130-6343(07)75407-7 · Cited by 5
The Changing Face of Prosthetic Valve Endocarditis at a Tertiary-Care Hospital: 1986-2005
Valle, H. A., Fariñas-Álvarez, C., Marco, J. M. B., García-Palomo, J. D., Gutiérrez-Díez, F., Martín‐Durán, R., de Berrazueta, J. R., González-Macías, J., Revuelta-Soba, J. M., & Fariñas, M. C. (2010) · Revista Española de Cardiología (English Edition) · doi:10.1016/s1885-5857(10)70006-2 · Cited by 5
Metadata
- Authors
- John, M. D. V., Hibberd, P. L., Karchmer, A. W., Sleeper, L. A., & Calderwood, S. B.
- Affiliations
- Massachusetts General Hospital (US)
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 1998-06
- Volume
- 26
- Issue
- 6
- Pages
- 1302-1309
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2133760184
- Semantic Scholar
- 9d5f29d77f9c25c389602dd99ad9594bbabf8b6f
- Cited by
- 153
- References
- 25
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 2 · 2022: 2 · 2021: 1 · 2019: 2 · 2018: 2 · 2017: 5 · 2016: 2 · 2015: 10 · 2014: 3 · 2013: 10 · 2012: 5
- FWCI
- 5.67
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Infective Endocarditis Diagnosis and Management
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Valve Diseases and Treatments
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Keywords
- Staphylococcus aureus, prosthetic valve endocarditis, mortality risk factors, valve replacement, cardiac complications, central nervous system complications, survival after diagnosis, antibiotic therapy, survivorship bias
- MeSH terms
- Adult, Aged, Endocarditis, Bacterial, Female, Heart Valve Prosthesis, Humans, Male, Middle Aged, Retrospective Studies, Risk Factors, Staphylococcal Infections, Cohort Studies, Prosthesis-Related Infections
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.